← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Iohexol currently has availability issues reported in 3 European registers: Germany, Ireland, Italy.
Shortage ATC V08AB02 · also listed as: Iohexol · IOEXOLO · data refreshed 9 September 2026
As of 9 September 2026, 3 of the 9 tracked registers list current availability issues for Iohexol, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2026-03-23 and has now been open for about 6 months. Where agencies state a cause, manufacturing problems lead with 4 of the 5 stated-cause reports, followed by quality issues with 1. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Registers in Germany, Ireland, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Iohexol is coded V08AB02 — a medicine acting on various — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage ACCUPAQUE 350 | 2026-05-22 | 2026-09-30 | Probleme in der Herstellung Alternatives: ACCUPAQUE 350 - Einreichungsnummer: 3004003 | register ↗ |
| 🇮🇪 Ireland | Shortage Omnipaque 350 mg I / ml Solution for Injection (Polypropylene) | 2026-03-26 | — | Quality issue (Multiple countries) Alternatives: Alternative(s) available — see the national register. | register ↗ |
| 🇮🇹 Italy | Shortage OMNIPAQUE + 2 more productsOMNIPAQUE OMNIPAQUE | 2026-03-23 | — | Problemi produttivi: forniture discontinue Alternatives: AIFA: an alternative treatment is available (ask your doctor). | register ↗ |
Every individual register entry for Iohexol in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | OMNIPAQUE | Shortage | 2026-07-16 | — | Problemi produttivi: forniture discontinue |
| 🇩🇪 DE | ACCUPAQUE 350 | Shortage | 2026-05-22 | 2026-09-30 | Probleme in der Herstellung |
| 🇮🇹 IT | OMNIPAQUE | Shortage | 2026-04-13 | — | Problemi produttivi: forniture discontinue |
| 🇮🇪 IE | Omnipaque 350 mg I / ml Solution for Injection (Polypropylene) | Shortage | 2026-03-26 | — | Quality issue (Multiple countries) |
| 🇮🇹 IT | OMNIPAQUE | Shortage | 2026-03-23 | — | Problemi produttivi: forniture discontinue |
Yes. As of 9 September 2026, availability issues are reported in: Germany, Ireland, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Iohexol: BfArM (Germany), HPRA (Ireland), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Iohexol — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/iohexol/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Iohexol availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/iohexol/">Iohexol shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>